Scientists at the institute are inching closer to a commercialisation for anti-malarial drugs.
Researchers at the Max Planck Institute are close to commercialising a range of anti-malarial drugs on a cost-effective large-scale.
The continuous flow system yields artemisinin derivatives. Artemisinin can be either isolated from a Chinese herb called sweet wormwood – artesimia annua – or produced using genetically engineered yeast. It is basis for the currently most efficient drugs against malaria.
The particular advance that the Max Planck scientists made has been figuring out how exactly to create artemisinin artificially. Extracting it…
